46 related articles for article (PubMed ID: 38618953)
1. DRAIC mediates hnRNPA2B1 stability and m
Wen Y; Yang X; Li Y; Zhao X; Ding A; Song D; Duan L; Cheng S; Zhu X; Peng B; Chang X; Zhang C; Yang F; Cheng T; Wang H; Zhang Y; Zhang T; Zheng S; Ren L; Gao S
Oncogene; 2024 May; ():. PubMed ID: 38811846
[TBL] [Abstract][Full Text] [Related]
2. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
Sufan RI; Jewett MA; Ohh M
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F1-6. PubMed ID: 15180922
[TBL] [Abstract][Full Text] [Related]
3. VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.
Lee H; Zhuang L; Gan B
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618953
[TBL] [Abstract][Full Text] [Related]
4. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
6. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
7. Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
Messai Y; Gad S; Noman MZ; Le Teuff G; Couve S; Janji B; Kammerer SF; Rioux-Leclerc N; Hasmim M; Ferlicot S; Baud V; Mejean A; Mole DR; Richard S; Eggermont AM; Albiges L; Mami-Chouaib F; Escudier B; Chouaib S
Eur Urol; 2016 Oct; 70(4):623-632. PubMed ID: 26707870
[TBL] [Abstract][Full Text] [Related]
8. Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.
Zhang C; Yu M; Hepperla AJ; Zhang Z; Raj R; Zhong H; Zhou J; Hu L; Fang J; Liu H; Liang Q; Jia L; Liao C; Xi S; Simon JM; Xu K; Liu Z; Nam Y; Kapur P; Zhang Q
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618952
[TBL] [Abstract][Full Text] [Related]
9. von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.
Shirole NH; Kaelin WG
Hematol Oncol Clin North Am; 2023 Oct; 37(5):809-825. PubMed ID: 37270382
[TBL] [Abstract][Full Text] [Related]
10. The roles and implications of RNA m
Deng X; Qing Y; Horne D; Huang H; Chen J
Nat Rev Clin Oncol; 2023 Aug; 20(8):507-526. PubMed ID: 37221357
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
Toledo RA; Jimenez C; Armaiz-Pena G; Arenillas C; Capdevila J; Dahia PLM
Endocr Rev; 2023 Mar; 44(2):312-322. PubMed ID: 36301191
[TBL] [Abstract][Full Text] [Related]
12. Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer.
Kaelin WG
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 36106637
[TBL] [Abstract][Full Text] [Related]
13. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
Zhang L; Luo X; Qiao S
Br J Cancer; 2022 Jul; 127(1):30-42. PubMed ID: 35249103
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
